Status:
COMPLETED
Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain
Lead Sponsor:
GlaxoSmithKline
Conditions:
Herpes Zoster
Eligibility:
All Genders
50+ years
Brief Summary
The purpose of this study is to collect data on the incidence, complications and impact on quality of life of herpes zoster (HZ) disease in adults \>=50 years of age in Spain. This study will also col...
Eligibility Criteria
Inclusion
- A male or female \>=50 years of age at the time of study enrolment presenting with acute HZ;
- HZ diagnosis for this HZ episode;
- is the subject's first outpatient diagnosis; OR
- took place at another site/ centre up to seven days before the initial visit for the present study;
- Ability to comply with study procedures\*;
- Written informed consent obtained from the subject\*. Note: \* will be applicable to secondary objectives only and not for the primary objective to calculate incidence.
Exclusion
- • Subject participating in another research study. Note: This exclusion criteria is applicable to secondary objectives only and not for the primary objectives to calculate incidence.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
552 Patients enrolled
Trial Details
Trial ID
NCT01521286
Start Date
March 1 2012
End Date
May 1 2015
Last Update
September 28 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Barcelona, Spain, 08034
2
GSK Investigational Site
Madrid, Spain, 28037
3
GSK Investigational Site
Valencia, Spain, 46020
4
GSK Investigational Site
Valencia, Spain, 46021